Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Clinical trial NCT02867891 · COMPLETED

Trial details

NCT number: NCT02867891
Sponsor: Robert Zeiser
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia

Start date: 2001-03-01
Primary completion: 2016-12-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.